North America Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological and Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)

Code: BMIRE00027551 | Pages: 169 | Industry: Medical Device | Date: Nov 2022 | Type: Regional

The embolotherapy market in North America is expected to grow from US$ 1,354.02 million in 2022 to US$ 2,245.73 million by 2028. It is estimated to grow at a CAGR of 8.8% from 2022 to 2028.

 

Rising Preference for Minimally Invasive Procedures Drives Growth of Embolotherapy Market in North America Patients increasingly prefer minimally invasive surgeries due to their various advantages such as low postoperative pain, less postoperative complications, short hospital stays, and fast recovery times. Trans Arterial Chemo Embolization (TACE) is a minimally invasive procedure that is typically used to treat hepatocellular carcinoma. TACE is used for patients suffering from asymptomatic and unresectable liver cancer. TACE can be used to diminish the size of the tumor and make the patient eligible for liver transplantation. It is considered an evolution from a formerly applied technique called Trans-catheter Arterial Embolization (TAE). Bleeding is a common issue in cancer patients, related to local tumor invasion, tumor angiogenesis, systemic effects of cancer, and anti-cancer treatments. TACE involves a two-step process—selective arterial occlusion restricts the blood supply to the tumor, which causes ischemic tumor necrosis, and regional chemotherapy helps the drug remain in the area for a prolonged period, which starts causing the therapeutic effects. Prostatic artery embolization (PAE) is also a minimally invasive therapy implemented as an elective outpatient technique for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The number of patients treated with PAE has grown in recent years. Thus, the increasing preference for minimally invasive procedures is fueling the embolotherapy market growth in North America.

 

Market Overview

The North America embolotherapy market is segmented into the US, Canada, and Mexico. The US held the largest share of the market in 2021, owing to the growing prevalence of hepatocellular cancer and liver cancer coupled with the increasing focus of the major manufacturers on technological advancements. Furthermore, the advanced healthcare sector of the region, the prevalence of sophisticated technological healthcare facilities. The embolotherapy market in the region is anticipated to grow significantly in the coming years owing to the rising cases of brain aneurysms. According to the Brain Aneurysm Foundation’s report, ~6 million people have unruptured brain aneurysms in the US. Also, the annual rate of rupture is nearly 8–10 per 100,000 people; ~30,000 people in the country suffer from a brain aneurysm rupture. In addition, about 4 out of 7 people who recover from a ruptured brain aneurysm are likely to suffer from the disabilities. This neurological disorder generally affects people who are in the age group of 35–60 years. However, the brain aneurysm can also be seen in children, and women in the country suffer more than men.

North America Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)

North America Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

               

North America Embolotherapy Market Segmentation

 

The North America embolotherapy market is segmented on the basis of product, disease indication, procedure, end user, and country.

  • Based on product, the North America embolotherapy market is bifurcated into embolic agents and support devices. The embolic agents segment held a larger market share in 2022.
  • Based on disease indication, the North America embolotherapy market is segmented into cancer, neurological diseases, urological and nephrological disorders, peripheral vascular diseases, gastrointestinal disorders, and others. The cancer segment held the largest market share in 2022. 
  • Based on procedure, the North America embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization/selective internal radiation therapy, and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment held the largest market share in 2022. 
  • Based on end user, the North America embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held the largest market share in 2022. 
  • Based on country, the North America embolotherapy market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022.

Abbott Laboratories, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, Balt USA LLC, Stryker Corporation, Guerbet LLC, and Terumo Corporation are among the leading companies operating in the embolotherapy market in North America.   

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Embolotherapy Market – by Product

1.3.2        North America Embolotherapy Market – by Disease Indication

1.3.3        North America Embolotherapy Market – by Procedure

1.3.4        North America Embolotherapy Market – by End User

1.3.5        North America Embolotherapy Market– By Country

2.           North America Embolotherapy Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Embolotherapy Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinion

5.           North America Embolotherapy Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Burgeoning Incidence of Cancer Cases

5.1.2        Boosting Patient Preference for Minimally Invasive Procedures

5.2         Market Restraints

5.2.1        Availability of Other Alternative Therapies

5.3         Market Opportunity

5.3.1        Elevating Applications of Embolotherapy

5.4         Market Trend

5.4.1        Widening Use of Liquid Embolic Agents

5.5         Impact analysis

6.           North America Embolotherapy Market Analysis

6.1         North America Embolotherapy Market Revenue Forecast and Analysis

7.           North America Embolotherapy Market – by Product

7.1         Overview

7.2         North America Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)

7.3         Embolic Agents

7.3.1        Overview

7.3.2        Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.3        Microspheres

7.3.3.1          Overview

7.3.3.2          Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.4        Embolic Coils

7.3.4.1          Overview

7.3.4.2          Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.5        Embolic Plug Systems

7.3.5.1          Overview

7.3.5.2          Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.6        Detachable Balloons

7.3.6.1          Overview

7.3.6.2          Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.7        Liquid Embolic Agents

7.3.7.1          Overview

7.3.7.2          Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.8        Others

7.3.8.1          Overview

7.3.8.2          Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4         Support Devices

7.4.1        Overview

7.4.2        Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.3        Microcatheters

7.4.3.1          Overview

7.4.3.2          Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.4        Guidewires

7.4.4.1          Overview

7.4.4.2          Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

8.           North America Embolotherapy Market Analysis – by Disease Indication

8.1         Overview

8.2         North America Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)

8.3         Cancer

8.3.1        Overview

8.3.2        Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1          Liver Cancer

8.3.2.1.1          Overview

8.3.2.1.2          Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.2          Kidney Cancer

8.3.2.2.1          Overview

8.3.2.2.2          Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.3          Other Cancers

8.3.2.3.1          Overview

8.3.2.3.2          Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Peripheral Vascular Diseases

8.4.1        Overview

8.4.2        Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Neurological Diseases

8.5.1        Overview

8.5.2        Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Urological and Nephrological Disorders

8.6.1        Overview

8.6.2        Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Gastrointestinal Disorders

8.7.1        Overview

8.7.2        Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.8         Others

8.8.1        Overview

8.8.2        Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Embolotherapy Market Analysis – by Procedure

9.1         Overview

9.2         North America Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)

9.3         Transcatheter Arterial Embolization (TAE)

9.3.1        Overview

9.3.2        Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)

9.4.1        Overview

9.4.2        Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Transarterial Chemoembolization (TACE)

9.5.1        Overview

9.5.2        Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.        North America Embolotherapy Market Analysis – By End User

10.1      Overview

10.2      North America Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)

10.3      Hospitals and Clinics

10.3.1     Overview

10.3.2     Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Ambulatory Surgical Centers

10.4.1     Overview

10.4.2     Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Other End Users

10.5.1     Overview

10.5.2     Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.        North America Embolotherapy Market – Country Analysis

11.1      North America Embolotherapy Market

11.1.1     North America: Embolotherapy Market, by Country, 2022 & 2028 (%)

11.1.1.1       US: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.1       US: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.2       US Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.2.1    US Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.2.2    US Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3       US Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3.1    US Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.4       US Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.5       US Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.2       Canada: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.1       Canada: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2       Canada Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2.1    Canada Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2.2    Canada Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3       Canada Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3.1    Canada Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.4       Canada Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.5       Canada Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.3       Mexico: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.1       Mexico: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.2       Mexico Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.2.1    Mexico Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.2.2    Mexico Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3       Mexico Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3.1    Mexico Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.4       Mexico Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.5       Mexico Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

12.        Embolotherapy Market –Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Abbott Laboratories

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Boston Scientific Corporation

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Cook Medical LLC

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Johnson & Johnson

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Medtronic

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Acandis GmbH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Balt USA LLC

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Stryker Corporation

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Guerbet LLC

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Terumo Corporation

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             US Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 5.             US Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 6.             US Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 7.             US Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 8.             Canada Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)

Table 9.             Canada Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)

Table 10.          Canada Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)

Table 11.          Canada Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)

Table 12.          Canada Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)

Table 13.          Canada Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)

Table 14.          Canada Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)

Table 15.          Mexico Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Mexico Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Mexico Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Mexico Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Mexico Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Mexico Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 21.          Mexico Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 22.          Organic Developments Done by Companies

Table 23.          Inorganic Developments Done by Companies

Table 24.          Glossary of Terms, North America Embolotherapy Market

 

 

LIST OF FIGURES

Figure 1.           North America Embolotherapy Market Segmentation

Figure 2.           North America Embolotherapy Market, By Country

Figure 3.           North America Embolotherapy Market Overview

Figure 4.           Embolic Agents Held Largest Share of Product Segment in Embolotherapy Market

Figure 5.           Embolotherapy Market in North America to Show Remarkable Growth During Forecast Period

Figure 6.           North America Embolotherapy Market, Industry Landscape

Figure 7.           North America PEST Analysis

Figure 8.           North America Embolotherapy Market Impact Analysis of Drivers and Restraints

Figure 9.           North America Embolotherapy Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        North America Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)

Figure 11.        Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.        North America Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)

Figure 22.        Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        North America Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)

Figure 32.        Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        North America Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)

Figure 36.        Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37.        Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        North America: Embolotherapy Market, by Key Country – Revenue (2022) (US$ Million)

Figure 40.        North America: Embolotherapy Market, by Country, 2022 & 2028 (%)

Figure 41.        US: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42.        Canada: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43.        Mexico: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

  1. Abbott Laboratories
  2. Boston Scientific Corporation
  3. Cook Medical LLC        
  4. Johnson & Johnson
  5. Medtronic
  6. Acandis GmbH  
  7. Balt USA LLC
  8. Stryker Corporation
  9. Guerbet LLC
  10. Terumo Corporation
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000